Loading
AB
Abattis Bioceuticals Corp. Stock: price and insider trades · Canada
Abattis Bioceuticals Corp.: what insiders have been doing
Every trade that managers of Abattis Bioceuticals Corp. disclose to SEDI is tracked on this page. No insider at Abattis Bioceuticals Corp. has published a filing in the past twelve months. The most recent one dates from 28 January 2019.
Looking back to 2016, when coverage begins, insiders filed 5 purchases and 74 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
180
Thresholds
n/a
Buy Volume
€20,733
5 ops. · all time
Sell Volume
€1M
74 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 28 January 2019
Declarations180 total
150,000 sharesCommon SharesTSXSEDI:3306497
150,000 shares@ CA$0.0950.2% of flowCommon SharesTSXSEDI:3269559
Common SharesTSXSEDI:3269556
100,000 shares@ CA$0.13549.8% of flowCommon SharesTSXSEDI:3254198
Common SharesTSXSEDI:3254197
4,677,625 shares@ CA$0.146320.8% of flowCommon SharesTSXSEDI:3221446
236,000 shares@ CA$0.158.2% of flowCommon SharesTSXSEDI:3218419
4,277,465 shares@ CA$0.127514.9% of flowCommon SharesTSXSEDI:3202514
1,000,000 shares@ CA$0.14624.0% of flowCommon SharesTSXSEDI:3202511
1,000,000 shares@ CA$0.174.7% of flowCommon SharesTSXSEDI:3200381
1,500,000 sharesCommon SharesTSXSEDI:3199469
3,000,000 shares@ CA$0.2721.8% of flowCommon SharesTSXSEDI:3152922
29,166 shares@ CA$0.27100.0% of flowCommon SharesTSXSEDI:3152251
3,000,000 shares@ CA$0.2724.0% of flowCommon SharesTSXSEDI:3152260
6,500,000 shares@ CA$0.262551.5% of flowCommon SharesTSXSEDI:3133051
4,500,000 shares@ CA$0.262532.3% of flowCommon SharesTSXSEDI:3132961
90,000 shares@ CA$0.597.7% of flowCommon SharesTSXSEDI:3121622
90,000 shares@ CA$0.597.7% of flowCommon SharesTSXSEDI:3121623
25,000 shares@ CA$0.672.4% of flowCommon SharesTSXSEDI:3120373
65,000 shares@ CA$0.67346.3% of flowCommon SharesTSXSEDI:3120372
762,379 shares@ CA$0.1613.4% of flowCommon SharesTSXSEDI:3119571
60,000 shares@ CA$0.605.3% of flowCommon SharesTSXSEDI:3118909
30,000 shares@ CA$0.612.7% of flowCommon SharesTSXSEDI:3118910
90,000 shares@ CA$0.536.9% of flowCommon SharesTSXSEDI:3118912
90,000 shares@ CA$0.597.7% of flowCommon SharesTSXSEDI:3118913
25 of 180 declarations
About Abattis Bioceuticals Corp.
Abattis Bioceuticals Corp. is a Canadian company focused on the development of bioceutical products derived from cannabis. It operates on the Toronto Stock Exchange (XTSE).
